Marinus Pharmaceuticals Provides Business Update, Reports Second Quarter 2023 Financial Results
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company, recently reported business highlights and financial results for the second quarter ended June 30, 2023.
Marinus Pharmaceuticals Provides Business Update, Reports Second Quarter 2023 Financial Results Read More